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Transient receptor potential ankyrin 1 (TRPA1) is an ion channel involved in thermosensation and
nociception. TRPA1 is activated by exogenous irritants and also by oxidants formed in inflammatory
reactions.However,ourunderstandingofitsroleininflammationislimited.Here,wetestedthehypothesis
that TRPA1 is involved in acute inflammatory edema. The TRPA1 agonist allyl isothiocyanate (AITC)
induced inflammatory edema when injected intraplantarly to mice, mimicking the classical response to
carrageenan. Interestingly, the TRPA1 antagonist HC-030031 and the cyclo-oxygenase (COX) inhibitor
ibuprofen inhibited not only AITC but also carrageenan-induced edema. TRPA1-deficient mice displayed
attenuated responses to carrageenan and AITC. Furthermore, AITC enhanced COX-2 expression in
HEK293 cells transfected with human TRPA1, a response that was reversed by HC-030031. This study
demonstratesahithertounknownroleofTRPA1 incarrageenan-induced inflammatoryedema.Theresults
also strongly suggest that TRPA1 contributes, in a COX-dependent manner, to the development of acute
inflammation.
T
heidentification oftransient receptor potentialankyrin 1 (TRPA1) asachemosensor ofpotentiallyharmful
electrophilic and non-electrophilic chemicals
1–4 has opened up new avenues in our understanding of noci-
ception and inflammatory pain
5. The role of TRPA1 in noxious chemosensation has attracted considerable
attention with regard to the development of TRPA1 antagonists in the treatment of pain and sensory hyperreac-
tivity, e.g. in the therapy of the urinary bladder and airway diseases
5–7.
TRPA1 is a membrane-associated cation channel which is involved in several physiological functions such as
neurotransmission, cell proliferation and gene expression via Ca




8,9. TRPA1 belongs to the transient receptor potential (TRP) ion channel superfamily
which in mammals embraces six subfamilies and 28 distinct proteins with different functions in a variety of cells
and tissues. TRPA1 was first discovered in 1999 by Jaquemar and colleagues
10 and is the only member of its
subfamily (TRP ankyrin) found in humans. Structurally, TRPA1 is composed of six transmembrane spanning
segments with a pore domain between 5
th and 6
th segments. The TRPA1 intracellular N-terminus displays 14
ankyrin repeats
11 within which lies the site of activation by the covalent modification of specific cysteines
11–13.
Many of the oxidants formed in inflammatory reactions such as nitro-oleic acid
14, 4-hydroxynonenal or
hydrogen peroxide
15 are endogenous agonists of TRPA1. Furthermore, a variety of exogenous agonists, for
example allyl isothiocyanate (AITC)
1, one of the pungent compounds in mustard oil, have been identified.
TRPA1 antagonists have also been developed and, e.g. HC-03003
16 has become a widely used experimental tool.
TRPA1isprimarilyconsideredtobeexpressedinasub-populationofsensoryneurons
3,11,17,butrecentfindings
suggest that it is also present in a number of other cells, including keratinocytes, endothelial cells, synoviocytes,
odontoblasts and enterochromaffin cells
18–22. Its physiological role remained obscure until the discovery that
TRPA1 is present in mouse afferent nerves and could be activated by noxious cold, indicating a role in thermal
nociception
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1,5.Inaddition,TRPA1hasbeenshownto
mediate inflammatory
23 and formalin-induced pain
24, irritating
effects of pungent compounds
25,26 and neurogenic inflammation
27,28.
Also, mice treated with TRPA1 antagonists and TRPA1 knock out
(KO) mice were found to develop a less severe ovalbumin-induced
asthmareactionthanuntreatedwildtype(WT)mice
29.Topicaltreat-
ment with mustard oil has been shown to induce local edema, an
effect also blunted in TRPA1 deficient mice
25. However, it is still far
from clear if TRPA1 has a role as a modulator of the inflammatory
process.
In the present study, we investigated the possible role of TRPA1 in
carrageenan-induced inflammatory paw edema which is a widely used
model for investigating the acute inflammatory response and novel
anti-inflammatory drugs. The results show that a substantial part of
the mouse paw edema triggered by carrageenan is dependent on
TRPA1. Furthermore, both carrageenan and AITC-induced edemas
are to a large extent inhibited by ibuprofen. These findings highlight
TRPA1 as a potential drug target for novel anti-inflammatory agents
that could be a valuable alternative to cyclo-oxygenase (COX) inhibi-
tors in the treatment of certain inflammatory conditions.
Results
Intraplantar (i.pl.) injection of carrageenan induced a substantial
paw edema when measured at 3 h and 6 h following injection
(Fig. 1A). The contralateral paw injected i.pl. with saline exhibited
no measurable edema. Likewise, the TRPA1 agonist AITC evoked a
severe edema when injected in the mouse paw (Fig. 1B).
To further study the role of TRPA1 in the inflammatory edema
induced by carrageenan and AITC, we treated the mice with the
selective TRPA1 antagonist HC-030031
16. The mice received
300 mg/kg of HC-030031 intraperitoneally (i.p.) 2 h before carra-
geenan or AITC was injected into the paw. HC-030031 treatment
prevented carrageenan-induced inflammatory edema by 48% and
40% when measured at 3 h and 6 h following the carrageenan injec-
tion, respectively (Fig. 1A). As expected, HC-030031 reduced the
AITC-induced edema response by 67% and 69% at 3 h and 6 h,
respectively (Fig. 1B).
Next we used TRPA1-deficient mice to confirm and extend the
results obtained with pharmacological blockade of TRPA1. We
found that such mice developed on average 62% and 50% less edema
as compared to WT mice when measured 3 h and 6 h following
the i.pl. carrageenan injection (Fig. 2A). AITC induced a negligible
edema in TRPA1 deficient mice (Fig. 2B) providing additional evid-
ence that the AITC-induced response is indeed dependent on
TRPA1.
ThepossibleinvolvementofCOX-derivedprostanoidsinTRPA1-
mediated inflammatory edema was investigated by treating the ani-
mals with ibuprofen. Ibuprofen (100 mg/kg i.p.) given 2 h before
carrageenan reduced the edema response by 51% and 49%, respect-
ively when measured at 3 h and 6 h following carrageenan injection
Figure 1 | TRPA1 agonist allyl isothiocyanate (AITC) and carrageenen (Car) induced an inflammatory paw edema, which could be prevented by pre-
treatment with HC-030031 (HC) or ibuprofen (Ibu.). HC-030031 (300 mg/kg) or ibuprofen (100 mg/kg) was injected intraperitoneally 2 h prior to
intraplantar injection of carrageenan or AITC into the hind paw. The edema was measured 3 h and 6 h after intraplantar injection and compared to the
basal level. The contralateral control paw injected with saline developed no measurable edema. Mean 1 SEM, n56, ***p,0.001.
Figure 2 | InTRPA1knockout(KO)mice,thecarrageenan-inducedpawedemaformationwasbluntedwhencomparedtothecorrespondingwildtype
(WT) mice (A). TRPA1-deficient mice showed almost no response to the TRPA1 agonist AITC (allyl isothiocyanate) in contrast to the WT mice (B).
Carrageenan or AITC were injected intraplantarly. The edema was measured after 3 h and 6 h and compared to the basal level. The contralateral control
paw injected with saline developed no measurable edema. Mean 1 SEM, n55, **p,0.01, ***p,0.001.
www.nature.com/scientificreports
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also clearly inhibited by ibuprofen pre-treatment. The mean edema
was about 60% less in ibuprofen treated than in vehicle treated mice
at both 3 h and 6 h time points (Fig. 1B). These results indicate that
prostanoids play an important role in mediating TRPA1-induced
edema.
To further investigate the link between TRPA1 and COX,
we transfected HEK 293 cells with human TRPA1. The COX-2
mRNA expression was up-regulated in TRPA1 transfected HEK
293 cells but not in non-transfected cells when they were exposed
to AITC. HC-030031 given 30 min before AITC reduced the extent
of the up-regulation of COX-2 mRNA triggered by TRPA1 stimu-
lation(Fig.3),supportingtheconceptthatCOX-derivedprostanoids
are involved in TRPA1-induced responses.
In addition, the direct activation of TRPA1 by carrageenan was
investigated in HEK 293 cells expressing human TRPA1. In those
cells,exposure tocarrageenan(250 mg/ml)didnotevokeachangein
the basal calcium level, as measured by ratiometric calcium imaging,
whereas subsequent addition of AITC (100 mM) always evoked
robust calcium responses (Fig. 4). Higher concentrations of carra-
geenan could not be tested due to viscosity problems.
Discussion
Thepresentstudyconfirms theeffectsofexogenous TRPA1agonists
on edema formation and, more interestingly, reveals a hitherto
unknown role of TRPA1 in carrageenan-induced inflammatory
pawedemawhichisawidelyusedmodelforevaluatingacuteinflam-
mation and anti-inflammatory drugs. The results strongly suggest
that TRPA1 has a significant role in mediating the acute inflammat-
ory response.
Previously, TRPA1 has been shown to mediate nociceptive pro-
cesses in vivo, such as mechanical and cold hyperalgesia
30–32, and also
inflammatory pain
23,24. A mutation in TRPA1 resulting in hyperfunc-
tion of the ion channel was recently associated with familial episodic
pain syndrome
33 highlighting the significant role of TRPA1 also in
human pain. Although endogenous TRPA1 agonists are produced in
inflammatoryreactions
14,verylittleisknownaboutthepossibleroleof
TRPA1 in mediating inflammatory responses in addition to pain.
Experiments conducted in knock out mice revealed that TRPA1 was
involved in the pathogenesis of airway hyperreactivity and inflam-
mation during ovalbumin-induced asthma
29. Exposure to a TRPA1
agonist extracted from cigarette smoke was reported to cause tracheal
edema which could be reversed by local administration of a TRPA1
antagonist whereas no edema formation occurred in TRPA1 KO ani-
mals
34. In the present study, we observed that activation of TRPA1 by
AITC resulted in inflammatory edema, and that a TRPA1-dependent
Figure 3 | HEK 293 cells transfected with human TRPA1 showed an upregulation of cyclo-oxygenase-2 (COX-2) mRNA in response to the TRPA1
agonist allyl isothiocyanate (AITC). The expression was suppressed when the TRPA1 antagonist HC-030031 (10 mM) was given before AITC. Both
TRPA1transfectedandnon-transfected(wildtype,WT)cellswereincubatedwithHC-030031orvehiclefor30 minandthereafterAITCwasadded.After
6 htheincubationswereterminatedandCOX-2mRNAwasassayedbyreal-timeRT-PCR.COX-2mRNAwasnormalizedagainstGAPDHmRNA.Mean
1 SEM, n54, *p,0.05, **p,0.01, n.s.5non-significant.
Figure 4 | In calcium imaging experiments, HEK 293 cells transfected
with human TRPA1 were exposed to either carrageenan or its vehicle for
60 s and subsequently to AITC (allyl isothiocyanate) for 36 s. Whereas
carrageenan or vehicle was without effect, AITC always evoked robust
calcium responses as assessed by ratiometric Fura 2 imaging. Traces show
the average calcium responses (A) and the bar graph (B) shows the
maximum calcium responses in cells exposed to the various treatments.
Mean 1 SEM, n54 (each experiment was performed in duplicate or
triplicate).
www.nature.com/scientificreports
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nan-induced paw edema.
The inflammatory edema following carrageenan injection in-
volves both neurogenic and non-neurogenic mechanisms which
have been strongly associated with prostaglandin production,
COX-2 up-regulation and the formation of reactive nitrogen and
oxygen species as well as cytokines and other inflammatory media-
tors
35–37. Many such pro-inflammatory agents can sensitize or activ-
ate TRPA1 either indirectly via G protein-coupled phospholipase C
and protein kinase A pathways or by directly interacting with
TRPA1
5. In the present study we showed that the TRPA1 antagonist
HC-030031 clearly inhibited the development of carrageenan-
induced edema while a direct TRPA1 agonist AITC evoked a carra-
geenan-like inflammatory response. To confirm our findings with
the TRPA1 agonist and antagonist in acute inflammatory edema, we
performedtheexperimentsalsoinTRPA1deficientanimals.Indeed,
the carrageenan-induced response was markedly attenuated in
TRPA1 KO mice, and only a minor response to AITC was detected.
When compared with previous reports on the acute phase of carra-
geenan-induced mouse paw edema, TRPA1 deficient mice showed a
quantitatively similar attenuated response as mice lacking Akt1
38,
endothelial nitric oxide-synthase
39 and the tumor necrosis factor a
receptor 1
40,41. Taken together, our results support the conclusion
that TRPA1 activation is involved in the pathogenesis of acute





5,16,24. AITC is present in many naturally occur-
ring plant-derived sources and has been shown to have antimi-
crobial
42,43, cytostatic and cancer protective
44 properties linked to
multitudinous cellular targets. Whether TRPA1 mediates these
effects is, however, unclear. As shown in the present study, AITC
evoked edema in wild type but not in TRPA1 deficient animals, and
in WT mice the AITC-response was inhibited by the TRPA1 ant-
agonist HC-030031. These data together suggest that the AITC-
induced edema response found in the present study was indeed
mediated by TRPA1.
Given that TRPA1 is a highly promiscuous chemosensor
5,45, one
cannot rule out the possibility that TRPA1 may also recognize car-
rageenan. Due to its high viscosity, we could not test the direct effect
of carrageenan in concentrations above 250 mg/ml on TRPA1. This
concentration is 40-60 times lower than stock solutions normally
used for intraplantar injections
37 and 8 times lower than the concen-
tration known to induce inflammation
46. However, the injected car-
rageenan is quickly diluted within the tissue and hence the local
concentrationsmaywellcorrespondtotheinvitrotestconcentration
that we found inactive at TRPA1 expressed in HEK 293 cells. Thus,
we believe that the inflammation triggered by carrageenan is most
likely not initiated by a direct interaction with TRPA1, but rather
involves TRPA1 at some subsequent step in the inflammatory cas-
cade.
The ability of ibuprofen to reduce both carrageenan and AITC-
inducededemasuggeststhatitinhibitsCOXdownstreamofTRPA1.
Cellular calcium influx through TRPA1 would trigger the calcium-
dependent release of prostaglandins and other pro-inflammatory
agents that may further sensitize TRPA1 and increase its cell surface
expression as occurs in sensory neurons
47,48. It is also possible that
TRPA1 activation increases prostaglandin production through
enhanced COX-2 expression. This is supported by our in vitro find-
ing that activation of TRPA1 by AITC can up-regulate the COX-2
transcript in HEK 293 cells. Accordingly, a significant role of [Ca
21]i
in regulating COX-2 expression in macrophages was recently
reported
49. Together these events would generate and maintain a
TRPA1 and COX-dependent inflammation. Our finding that the
TRPA1 antagonist HC-030031 is as effective as the COX inhibitor
ibuprofen to inhibit the development of carrageenan and AITC-
induced edema is promising, and may help to develop safer anti-
inflammatory drugs than existing COX inhibitors.
An interesting question remains on the mechanisms behind
TRPA1-mediated inflammatory edema which may involve neuro-
genic and/or non-neurogenic components. TRPA1 activation in
afferent nerve endings may lead to a focal release of bioactive com-
pounds such as calcitonin gene-related peptide (CGRP) and sub-
stance P which play a major role in neurogenic inflammation and
exert vascular effects which may contribute to the formation of
inflammatory edema
5. However, spinal TRPA1 may also regulate
the peripheral responses through retrograde afferent signaling
30.I n
addition, activation of TRPA1 on vascular sensory neurons and/or
endothelium
50 can lead to vasodilatation and increased vascular per-
meabilityandedemaformation
51.Sinceendotheliumisalsoaknown
source of vasodilating and edema-evoking prostaglandins and other
prostanoids, this could provide an explanation for the link between
TRPA1 and COX, as observed in the present study.
Inhumans,TRPA1ispresentonnociceptivenerveendingsandin
non-neuronalcellssuchaskeratinocytesandfibroblasts,fromwhich
prostaglandins and other mediators may be released after TRPA1
activation
52,53. Therefore, the mouse carrageenan-induced paw
edemamaybeausefulmodeltoidentifynovelcompoundsanddrugs
targeting TRPA1 in humans.
Our study demonstrates a significant role for TRPA1 in the
development of acute inflammation, and suggests that TRPA1
antagonists may have anti-inflammatory properties in addition to
their previously recognized analgesic effects in inflammatory pain.
Methods
Wild type and TRPA1-deficient C57BL/6 mice were used in the experiments.
TRPA1-deficient mice and the corresponding WT mice were originally obtained
from Dr David Julius (UCSF) and back-crossed in the laboratory of EDH and PMZ
(Lund University, Sweden). TRPA1 genotype was confirmed by PCR. The mice were
housed under standard conditions (12:12 h light-dark cycle, 2261uC, 50–60%
humidity) with food and water provided ad libitum.
The mice were divided into groups of six and were treated with 150 ml of saline
(vehicle), ibuprofen (100 mg/kg, Sigma Chemical Co., St. Louis, MO, USA) or HC-
030031 (300 mg/kg, Sigma Chemical Co.) i.p. 2 h before administering carrageenan
orAITC.Beforeinducingthepawedema,themicewereanesthesizedbyi.p.injection
of 0.5 mg/kg medetomidine (DomitorH, Orion Oyj, Espoo, Finland) and 75 mg/kg
ketamine (KetalarH, Pfizer Oy Animal Health, Helsinki, Finland). To induce the
edema, mice received ipsilaterally i.pl. injection (30 ml) of either l-carrageenan
(15 mg/ml, Sigma Chemical Co.) or AITC (6.66 mM, Sigma Chemical Co.) into the
hind paw. The control paw was injected with 30 ml of saline and developed no
measurable edema. The study was approved by the National Animal Experiment
Board.
Edema was measured before and at 3 h and 6 h after carrageenan or AITC injec-
tion by using a plethysmometer (Ugo Basile, Comerio, Italy). Edema is expressed as
thedifferencebetweenthecarrageenanorAITCtreatedpawatthetimeindicatedand
the basal level.
HEK 293 human embryonic kidney cells (American Type Culture Collection,
Manassas, VA, USA) were cultured in Eagle’s Minimum Essential Medium (EMEM)
supplemented with 10% heat-inactivated fetal bovine serum, sodium bicarbonate
(1.5%), sodium pyruvate (1 mM), non-essential amino acids (1 mM each) (all from
Lonza , Verviers SPRL, Verviers, Belgium), penicillin (100 U/ml), streptomycin
(100 mg/ml)and amphotericin B (thelast three compounds from Invitrogen, Paisley,
UK)at37uCin5%CO 2.Thecells weretransfectedusing 0.42 mg/cm
2human TRPA1
plasmid DNA (pCMV6-XL4 by Origene Rockville, MD, USA) with Lipofectamine
2000 (Invitrogen) according to the manufacturer’s directions. After 24 h of trans-
fection, HC-030031 (10 mM) or solvent (control) was added to the cells in fresh
culturemedium30 minpriortotheactivationofTRPA1byAITC(10 mM).Thecells
were then incubated for 6 h before being harvested for RNA extraction. Similar
experiments were carried out by using non-transfected (wild type, WT) HEK 293
cells.
Total RNA extraction was carried out with the use of GenElute
TM Mammalian
Total RNA Miniprep Kit (Sigma). Reverse-transcription of RNA to cDNA and
quantitative RT-PCR reactions were performed as previously described
54. TRPA1
expression was measured by using TaqMan Gene Expression Assay (Applied
Biosystems, Foster City, CA, USA). COX-2 and GAPDH primers and probes were
identical to those previously described
55. COX-2 mRNA levels were normalized
against GAPDH.
Fluorometric calcium imaging was used to study the effect of carrageenan on
human TRPA1 expressed in HEK 293 cells. The cells were plated in 96-well black-
walled plates (Costar, Cambridge, MA, USA) and loaded with Fura 2-AM (1 mM,
www.nature.com/scientificreports
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Invitrogen) for 1 h at 37uC. The cells were then washed with physiological buffer
solution (PBS), containing 140 mM NaCl, 5 mM KCl, 10 mM glucose, 10 mM
HEPES, 2 mM CaCl2 and 1 mM MgCl2, and allowed to equilibrate for a period of
30 min in the dark before the start of the experiments. The intracellular calcium
concentration was determined at 25uC in a Flexstation 3 (Molecular Devices,
Sunnyvale, CA, USA). Basal emission (510 nm) ratios with excitationwavelengthsof
340 nm and 380 nm were measured and changes in dye emission ratio (D ratio)
determined at various times after compound addition.
Resultsareexpressed asmean6standard errorofmean(SEM). Statistical analysis
was carried out by using Student’s t-test or one-way ANOVA with Bonferroni’s
multiple comparisons test and results were considered significant at *p,0.05,
**p,0.01 and ***p,0.001.
1. Jordt, S. et al. Mustard oils and cannabinoids excite sensory nerve fibres through
the TRP channel ANKTM1. Nature 427, 260–265 (2004).
2. Bandell, M. et al. Noxious cold ion channel TRPA1 is activated by pungent
compounds and bradykinin. Neuron 41, 849–857 (2004).
3. Bautista, D. M. et al. Pungent products from garlic activate the sensory ion
channel TRPA1. Proc. Natl. Acad. Sci. U. S. A. 102, 12248–12252 (2005).
4. Macpherson, L. J. et al. The pungency of garlic: activation of TRPA1 and TRPV1
in response to allicin. Curr. Biol. 15, 929–934 (2005).
5. Baraldi, P. G., Preti, D., Materazzi, S. & Geppetti, P. Transient Receptor Potential
Ankyrin 1 (TRPA1) Channel as Emerging Target for Novel Analgesics and Anti-
Inflammatory Agents. J. Med. Chem. 53, 5085–5107 (2010).
6. Bessac, B. F. & Jordt, S. E. Breathtaking TRP channels: TRPA1 and TRPV1 in
airway chemosensation and reflex control. Physiology (Bethesda) 23, 360–370
(2008).
7. Andersson, K. E., Gratzke, C. & Hedlund, P. The role of the transient receptor
potential (TRP) superfamily of cation-selective channels in the management of
the overactive bladder. BJU Int. 106, 1114–1127 (2010).
8. Pedersen,S.F.,Owsianik,G.&Nilius,B.TRPchannels:anoverview.CellCalcium
38, 233–252 (2005).
9. Berridge, M. J., Lipp, P. & Bootman, M. D. The versatility and universality of
calcium signalling. Nat. Rev. Mol. Cell Biol. 1, 11–21 (2000).
10. Jaquemar, D., Schenker, T. & Trueb, B. An Ankyrin-like Protein with
TransmembraneDomainsIsSpecificallyLostafter OncogenicTransformationof
Human Fibroblasts. Journal of Biological Chemistry 274, 7325–7333 (1999).
11. Story, G. M. et al. ANKTM1, a TRP-like Channel Expressed in Nociceptive
Neurons, Is Activated by Cold Temperatures. Cell 112, 819–829 (2003).
12. Hinman, A., Chuang, H., Bautista, D. M. & Julius, D. TRP channel activation by
reversible covalent modification. Proceedings of the National Academy of Sciences
103, 19564–19568 (2006).
13. Sadofsky, L. R. et al. TRPA1 is activated by direct addition of cysteine residues to
the N-hydroxysuccinyl esters of acrylic and cinnamic acids. Pharmacol. Res. 63,
30–36 (2011).
14. Taylor-Clark, T. E., Ghatta, S., Bettner, W. & Undem, B. J. Nitrooleic acid, an
endogenous product of nitrative stress, activates nociceptive sensory nerves via
the direct activation of TRPA1. Mol. Pharmacol. 75, 820–829 (2009).
15.Andersson,D.A.,Gentry,C.,Moss,S.&Bevan,S.TransientreceptorpotentialA1
is a sensory receptor for multiple products of oxidative stress. J. Neurosci. 28,
2485–2494 (2008).
16. Eid, S. R. et al. HC-030031, a TRPA1 selective antagonist, attenuates
inflammatory- and neuropathy-induced mechanical hypersensitivity. Mol. Pain
4, 48 (2008).
17.Nagata,K.,Duggan,A.,Kumar,G.&Garcia-Anoveros,J.Nociceptorandhaircell
transducer properties of TRPA1, a channel for pain and hearing. J. Neurosci. 25,
4052–4061 (2005).
18. Nozawa, K. et al. TRPA1 regulates gastrointestinal motility through serotonin
releasefromenterochromaffincells.Proc.Natl.Acad.Sci.U.S.A.106,3408–3413
(2009).
19. Kwan, K. Y., Glazer, J. M., Corey, D. P., Rice, F. L. & Stucky, C. L. TRPA1
modulates mechanotransduction in cutaneous sensory neurons. J. Neurosci. 29,
4808–4819 (2009).
20.Streng,T.etal.Distributionandfunctionofthehydrogensulfide-sensitiveTRPA1
ion channel in rat urinary bladder. Eur. Urol. 53, 391–399 (2008).
21. Kochukov, M. Y., McNearney, T. A., Fu, Y. & Westlund, K. N. Thermosensitive
TRP ion channels mediate cytosolic calcium response in human synoviocytes.
Am. J. Physiol. Cell. Physiol. 291, C424–32 (2006).
22. El Karim, I. A. et al. Human odontoblasts express functional thermo-sensitive
TRP channels: implications for dentin sensitivity. Pain 152, 2211–2223 (2011).
23. Chen, J. et al. Selective blockade of TRPA1 channel attenuates pathological pain
withoutalteringnoxiouscoldsensationorbodytemperatureregulation.Pain152,
1165–1172 (2011).
24.McNamara, C.R. etal.TRPA1 mediatesformalin-induced pain. Proc.Natl.Acad.
Sci. U. S. A. 104, 13525–13530 (2007).
25.Bautista,D.M.etal.TRPA1 mediatesthe inflammatory actionsofenvironmental
irritants and proalgesic agents. Cell 124, 1269–1282 (2006).
26. Bessac, B. F. et al. Transient receptor potential ankyrin 1 antagonists block the
noxious effects of toxic industrial isocyanates and tear gases. FASEB J. 23, 1102–
1114 (2009).
27. Wei, H., Koivisto, A. & Pertovaara, A. Spinal TRPA1 ion channels contribute to
cutaneous neurogenic inflammation in the rat. Neurosci. Lett. 479, 253–256
(2010).
28. Nassini, R. et al. Acetaminophen, via its reactive metabolite N-acetyl-p-benzo-
quinoneimine and transient receptor potential ankyrin-1 stimulation, causes
neurogenic inflammation in the airways and other tissues in rodents. FASEB J.
(2010).
29. Caceres, A. I. et al. A sensory neuronal ion channel essential for airway
inflammation and hyperreactivity in asthma. Proceedings of the National
Academy of Sciences 106, 9099–9104 (2009).
30. da Costa, D. S. et al. The involvement of the transient receptor potential A1
(TRPA1) in the maintenance of mechanical and cold hyperalgesia in persistent
inflammation. Pain 148, 431–437 (2010).
31. Fernandes, E. S. et al. A distinct role for transient receptor potential ankyrin 1, in
addition to transient receptor potential vanilloid 1, in tumor necrosis factor a-
induced inflammatory hyperalgesia and Freund’s complete adjuvant-induced
monarthritis. Arthritis & Rheumatism 63, 819–829 (2011).
32. Petrus, M. et al. A role of TRPA1 in mechanical hyperalgesia is revealed by
pharmacological inhibition. Mol. Pain 3, 40 (2007).
33. Kremeyer, B. et al. A Gain-of-Function Mutation in TRPA1 Causes Familial
Episodic Pain Syndrome. Neuron 66, 671–680 (2010).
34.Andre `,E.etal.Cigarettesmoke-inducedneurogenicinflammationismediatedby
alpha,beta-unsaturated aldehydes and the TRPA1 receptor in rodents. J. Clin.
Invest. 118, 2574–2582 (2008).
35.Posadas, I.etal.Carrageenan-inducedmousepawoedemaisbiphasic,age-weight
dependent and displays differential nitric oxide cyclooxygenase-2 expression. Br.
J. Pharmacol. 142, 331–338 (2004).
36. Fantone, J. C. & Ward, P. A. Role of oxygen-derived free radicals and metabolites
in leukocyte-dependent inflammatory reactions. Am. J. Pathol. 107, 395–418
(1982).
37.Morris,C.J.Carrageenan-inducedpawedemaintheratandmouse.MethodsMol.
Biol. 225, 115–121 (2003).
38.DiLorenzo,A.,Fernandez-Hernando,C.,Cirino,G.&Sessa,W.C.Akt1iscritical
for acute inflammation and histamine-mediated vascular leakage. Proc. Natl.
Acad. Sci. U. S. A. 106, 14552–14557 (2009).
39. Bucci, M. et al. Endothelial nitric oxide synthase activation is critical for vascular
leakageduringacuteinflammationinvivo.Proc.Natl.Acad.Sci.U.S.A.102,904–
908 (2005).
40. Rocha, A. C., Fernandes, E. S., Quintao, N. L., Campos, M. M. & Calixto, J. B.
Relevance of tumour necrosis factor-alpha for the inflammatory and nociceptive
responses evoked by carrageenan in the mouse paw. Br. J. Pharmacol. 148, 688–
695 (2006).
41.Mazzon,E.etal.Effectoftumournecrosisfactor-alphareceptor1geneticdeletion
on carrageenan-inducedacute inflammation: a comparison withetanercept. Clin.
Exp. Immunol. 153, 136–149 (2008).
42. Schirmer, B. C. & Langsrud, S. Evaluation of natural antimicrobials on typical
meat spoilage bacteria in vitro and in vacuum-packed pork meat. J. Food Sci. 75,
M98–M102 (2010).
43. Obaidat, M. M. & Frank, J. F. Inactivation of Salmonella and Escherichia coli
O157:H7 on sliced and whole tomatoes by allyl isothiocyanate, carvacrol, and
cinnamaldehyde in vapor phase. J. Food Prot. 72, 315–324 (2009).
44. Zhang, Y. Allyl isothiocyanate as a cancer chemopreventive phytochemical.
Molecular Nutrition & Food Research 54, 127–135 (2010).
45.Holzer,P.Transientreceptorpotential(TRP)channelsasdrugtargetsfordiseases
of the digestive system. Pharmacol. Ther. 131, 142–170 (2011).
46.Henriques,M.G.etal.Mousepawedema.Anewmodelforinflammation?Braz.J.
Med. Biol. Res. 20, 243–249 (1987).
47. Materazzi, S. et al. Cox-dependent fatty acid metabolites cause pain through
activation of the irritant receptor TRPA1. Proc. Natl. Acad. Sci. U. S. A. 105,
12045–12050 (2008).
48.Schmidt,M.,Dubin,A.E.,Petrus,M.J.,Earley,T.J.&Patapoutian,A.Nociceptive
signals induce trafficking of TRPA1 to the plasma membrane. Neuron 64,4 9 8 –
509 (2009).
49. Jakobsson, P. Pain: How macrophages mediate inflammatory pain via ATP
signaling. Nat Rev Rheumatol 6, 679–681 (2010).
50. Earley, S., Gonzales, A. L. & Crnich, R. Endothelium-dependent cerebral artery
dilation mediated by TRPA1 and Ca21-Activated K1 channels. Circ. Res. 104,
987–994 (2009).
51. Graepel, R. et al. 4-Oxo-2-nonenal (4-ONE): Evidence of Transient Receptor
Potential Ankyrin 1-Dependent and -Independent Nociceptive and Vasoactive
Responses In Vivo. Journal of Pharmacology and Experimental Therapeutics 337,
117–124 (2011).
52. Atoyan, R., Shander, D. & Botchkareva, N. V. Non-neuronal expression of
transient receptor potential type A1 (TRPA1) in human skin. J. Invest. Dermatol.
129, 2312–2315 (2009).
53. Jain, A. et al. TRP-channel-specific cutaneous eicosanoid release patterns. Pain
152, 2765–2772 (2011).
54. Nieminen, R., Lahti, A., Jalonen, U., Kankaanranta, H. & Moilanen, E. JNK
inhibitorSP600125reducesCOX-2expressionbyattenuatingmRNAinactivated
murine J774 macrophages. 6, 987–996 (2006).
55. Nieminen, R., Korhonen, R., Moilanen, T., Clark, A. R. & Moilanen, E.
Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 380 | DOI: 10.1038/srep00380 5interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1
expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel
target for antirheumatic drugs. Arthritis Rheum. 62, 1650–1659 (2010).
Acknowledgements
We wish to thank Ms Petra Miikkulainen for technical assistance and Mrs Heli Ma ¨a ¨tta ¨ for
secretarial help. The study was supported by grants from the Medical Research Fund of
Tampere University Hospital, Finland; Tampere Tuberculosis Foundation, Finland; the
Medical Faculty of Lund (ALF) and the Swedish Research Council (2007–3095, 2010–
3347). The authors thank Peter McIntyre, University of Melbourne, for providing the
human TRPA1-inducible cell line.
Author contribution
LJM participated in the animal and laboratory experiments, calculated the results and
statisticsanddraftedthemanuscript.ML,MK,RK,TLandRMNparticipatedintheanimal
and the laboratory experiments. EDH and PMZ provided the TRPA1 knock out and
corresponding wild type animals and carried out the calcium imaging experiments. EM
conceived and supervised the study and helped to draft the manuscript. All authors were
involved in the planning of the study and in writing the manuscript.
Additional information
Competing financial interests: The authors declare no competing financial interests.
License: This work is licensed under a Creative Commons
Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this
license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Howtocitethisarticle:Moilanen,L.J.etal.TRPA1ContributestotheAcuteInflammatory
Response and Mediates Carrageenan-Induced Paw Edema in the Mouse. Sci. Rep. 2, 380;
DOI:10.1038/srep00380 (2012).
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 380 | DOI: 10.1038/srep00380 6